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Christopher J. Abularrage, MD,a Baltimore, Md
Objective: Previous studies have shown that female gender is associated with increased morbidity and mortality after
endovascular abdominal aortic aneurysm repair. The goal of this study was to assess the effect of gender on 30-day
outcomes after thoracic endovascular aortic aneurysm repair (TEVAR) using the American College of Surgeons
National Surgical Quality Improvement Program (ACS-NSQIP) database.
Methods: This was a review of the 2005 to 2011 ACS-NSQIP database to identify all patients who underwent TEVAR for
nonruptured thoracic aortic aneurysms. Procedure and diagnosis codes were used to capture the study population.
Patients were stratiﬁed according to gender. Baseline, operative, and outcomes data were compared in bivariate fashion.
The primary outcome measure was 30-day mortality, and a risk-adjusted generalized linear model with Poisson distri-
bution was used to identify relative risk.
Results: During the study period, 649 patients, 279 women (43%) and 370 men (57%), underwent TEVAR. Baseline
demographics according to gender were similar; however, women were less likely to drink alcohol (1% vs 5%; P [ .001)
and to have a history of cardiac surgery (14% vs 27%; P < .001). More women required iliac artery exposure (18% vs 7%;
P < .001). Operative times (173.66 6.3 vs 159.86 5.2 minutes; P[ .03), transfusion rates (30% vs 17%, P[ .001), and
hospital length of stay (7.7 6 0.5 vs 7.6 6 0.5 days; P [ .009) were increased in women compared with men. Overall,
postoperative complications were similar, but unadjusted mortality was signiﬁcantly greater in women (6% vs 3%;
P[ .03). On multivariable analysis, female gender was no longer a signiﬁcant predictor of mortality (relative risk [RR],
2.30; 95% conﬁdence interval [CI], 0.99-5.34; P [ .053). Independent predictors of 30-day mortality included
increasing age (RR, 1.05; 95% CI, 1.01-1.09; P[ .02), emergency procedure (RR, 3.76; 95% CI, 1.79-7.87; P < .001),
and iliac artery exposure (RR, 4.42; 95% CI, 2.07-9.44; P < .001).
Conclusions: Thirty-day unadjusted mortality after TEVAR for nonruptured thoracic aortic aneurysms is increased
in women compared with men, but this univariate ﬁnding did not persist after risk adjustment. Multivariable analysis
showed need for iliac artery exposure, age, and emergency surgery were independently associated with higher mortality
rates. These results suggest a need for decreased device delivery size and improvements in endovascular technology.
(J Vasc Surg 2014;59:45-51.)Thoracic endovascular aortic aneurysm repair (TEVAR)
for treatment of descending thoracic aortic aneurysms
(DTAAs) was ﬁrst described in the mid-1990s.1 Since U.S.
Food and Drug Administration approval for use of the
endograft device in 2005, several prospective, multi-
institutional studies have been performed, citing fewer
complications, shorter hospital stays, and improved
aneurysm-related mortality compared with open repair.2-7
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://dx.doi.org/10.1016/j.jvs.2013.06.058associated with poor outcomes after TEVAR, including
perioperative myocardial infarction or stroke, postoperative
endoleak, and emergent repair in the elderly.2,4,5,7,8
Previous studies have included the inﬂuence of gender
on outcomes after TEVAR; however, these have largely
been secondary observations. As well, many studies were
single-institution series and are thus limited by relatively
small sample size.9 No study to date has performed an
in-depth analysis examining the characteristics of TEVAR
patients based on gender in an effort to identify an inde-
pendent association. A single-institution series identiﬁed
female gender as an independent predictor of worse
mortality after elective endovascular abdominal aortic
aneurysm (AAA) repair.10 Additionally, a recent report
by Abedi et al11 used the American College of Surgeons
National Surgical Quality Improvement Program (ACS-
NSQIP) database to study the effect of female gender on
outcomes after AAA repair.11 They observed that unad-
justed mortality rates were higher in women; however,
this ﬁnding did not persist on multivariable analysis. In
addition, TEVAR patients were not included. We therefore
used the NSQIP database to test the hypothesis that female
gender is independently associated with a higher risk of 30-
day mortality after TEVAR.45
Table I. Patient demographics
Variablea
Female
(n ¼ 279)
Male
(n ¼ 370) P
Age, years 71.3 6 0.7 69.9 6 0.7 .34
Body mass index, kg/m2 26.3 6 0.4 27.0 6 0.4 .27
Current smoker 87 (31) 135 (36) .16
Alcohol use 2 (1) 20 (5) .001
Hypertension 250 (90) 316 (85) .11
Angina 13 (5) 11 (3) .26
Myocardial infarction 3 (1) 6 (2) .56
Congestive heart failure 2 (1) 5 (1) .44
Previous PCI 37 (13) 59 (16) .34
Previous cardiac surgery 40 (14) 99 (27) <.001
Peripheral vascular disease 23 (8) 32 (9) .86
Critical limb ischemia 0 (0) 4 (1) .08
Dyspnea .24
None 175 (63) 252 (68)
Moderate exertion 97 (35) 106 (29)
At rest 7 (3) 12 (3)
COPD 51 (18) 82 (22) .23
Current pneumonia 5 (2) 3 (1) .26
Ventilator dependent 4 (1) 8 (2) .50
Diabetes mellitus .14
Diet controlled 24 (9) 35 (9)
Insulin independent 5 (2) 7 (2)
Insulin dependent 12 (4) 5 (1)
Acute renal failure 1 (0.4) 3 (1) .47
Dialysis 6 (2) 10 (3) .65
TIA 22 (8) 32 (9) .72
Stroke 38 (14) 49 (13) .89
With deﬁcit 20 (7) 27 (7) .95
Without deﬁcit 18 (6) 23 (6) .90
Preoperative hematocrit, % 36.6 6 0.3 38.4 6 0.3 <.001
Bleeding disorder 14 (5) 31 (8) .10
Functional status .36
Independent 204 (73) 289 (78)
Partially dependent 9 (3) 11 (3)
Totally dependent 0 (0) 1 (0.3)
Prior operation # 30 days 23 (9) 40 (11) .27
COPD, Chronic obstructive pulmonary disease; PCI, percutaneous coro-
nary intervention; TIA, transient ischemic attack.
aContinuous data are shown as the mean 6 standard error and categoric
data as number of patients (%).
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The Johns Hopkins Medicine Institutional Review
Board approved this study.
Data source. This was a retrospective review of
prospectively collected data in the ACS-NSQIP database.
To achieve quality assessment and improvement, the ACS-
NSQIP has reported risk-adjusted surgical outcomes from
the private sector since 1999. At each participating insti-
tution, nurse reviewers prospectively record preoperative,
operative, and postoperative data from patients undergoing
major surgical procedures, in concert with a standardized
protocol.12
Methodical sampling was performed by entering the
ﬁrst 40 operations for a given nurse reviewer during an
8-day cycle from the operating room schedule to ensure
that no speciﬁc operating suite block time would inﬂuence
the weighting of cases. Data are recorded throughout the
30-day postoperative period, even in instances where the
patient is discharged #30 days from the index surgical
procedure. The data set provides access to 97 total vari-
ables, including 41 patient-related preoperative risk factors,
15 intraoperative and procedure-related variables, and
25 variables related to 30-day outcomes. Details of the
ACS-NSQIP database are reported elsewhere.11
Eligibility criteria. Patients undergoing TEVAR
procedures for nonruptured DTAA (postoperative diagnosis
International Classiﬁcation of Diseases, 9th Revision
[ICD-9] code 441.2) in the ACS-NSQIP database from
2005 to 2011 were included in this study. Patients with
a rupturedDTAAwere excluded from this analysis due to the
elevated risk of mortality. TEVAR procedures were identiﬁed
based on Current Procedural Terminology (CPT; American
Medical Association, Chicago, Ill) codes 33,880 and 33,881.
To identify patients requiring iliac or brachial artery exposure,
the CPT codes 34,833 and 34,834 were used. Proximal
extension prostheses were identiﬁed usingCPT codes 33,883
and 33,884, and the performance of left subclavian artery
revascularization procedures was determined usingCPT codes
33,889, 35,694, 35,695 or 33,891, 35,606, and 35,506.
Clinical variables. ACS-NSQIP clinical and operative
parameters used as adjustment variables were predeﬁned
and included in Tables I-III.13 Current smoking was
deﬁned as smoking#1 year of the index operation. Ethanol
abuse was considered two or more daily drinks during
the 2-week period immediately before surgery. Hyperten-
sion and diabetes mellitus were considered positive only if
the patient required medication for treatment of these
ailments. Other clinical variables included were age, body
mass index, angina, myocardial infarction, congestive heart
failure, previous coronary interventions, peripheral vascular
disease, pulmonary status, renal dysfunction, cerebrovas-
cular disease, and functional status. Operative factors in-
cluded the type of anesthesia used, surgeon specialty,
American Society of Anesthesiology classiﬁcation, operative
time, and emergency status of the procedure.
Outcomes. The primary outcome analyzed was
30-day mortality. Secondary outcomes included anypostoperative morbidity, deﬁned by the ACS-NSQIP as the
occurrence of one or more of 21 adverse events. Hospital
length of stay was separately examined. Additional
subclassiﬁcations of postoperative adverse events included
wound, respiratory, renal, neurologic, cardiac, bleeding,
thromboembolic, and infectious complications, as well as
prosthesis failure and need for reoperation. Detailed
description of these subclassiﬁcations have been described
previously.12,14
Statistical analysis. The cohort was stratiﬁed accord-
ing to gender. Preoperative risk factors and procedure-
related characteristics were compared using the Wilcoxon
rank-sum test for continuous variables and the c2 test for
categoric variables. Thirty-day unadjusted mortality rates
were compared based on gender using a c2 analysis. To
examine the independent effect of gender on 30-day
mortality, we estimated the relative risk (RR) by con-
structing risk-adjusted generalized linear models, with
a Poisson distribution and log link, as described by Zou.15
Table II. Operative characteristics
Variablea
Female
(n ¼ 279)
Male
(n ¼ 370) P
Anesthesia .18
Epidural 1 (0.4) 3 (1)
General 270 (97) 338 (91)
MAC 1 (0.4) 5 (1)
Regional 0 (0) 1 (0.3)
Spinal 7 (3) 20 (5)
Other 0 (0) 2 (1)
Surgical speciality .33
General surgery 6 (2) 3 (1)
Vascular surgery 271 (97) 361 (98)
Cardiac surgery 2 (1) 5 (1)
Thoracic surgery 0 (0) 1 (0.3)
Residency supervision .56
Attending and resident 54 (19) 58 (16)
Attending alone 30 (11) 39 (11)
Attending not present 0 (0) 1 (0.3)
Attending in OR 195 (70) 271 (73)
Operative time, minutes 148 6 6 130 6 5 .03
Transfused 63 (30) 52 (17) .001
PRBC transfusion, units 1.0 6 0.2 0.5 6 0.1 .002
ASA class .29
1 0 (0) 1 (0.3)
2 16 (6) 9 (2)
3 176 (63) 240 (65)
4 86 (31) 118 (32)
5 1 (0.4) 1 (0.3)
Emergency 13 (5) 30 (8) .08
ASA, American Society of Anesthesiologists; MAC, monitored anesthesia
care; OR, operating room; PRBC, packed red blood cells.
aContinuous data are shown as the mean 6 standard error and categoric
data as number of patients (%).
Table III. Intraoperative anatomic characteristics
Variable
Female
(n ¼ 279),
No. (%)
Male
(n ¼ 370),
No. (%) P
TEVAR
With LSCA coverage 82 (29) 128 (35) .16
Without LSCA coverage 197 (71) 242 (65) .16
Proximal extension 50 (18) 54 (15) .25
LSCA revascularization 14 (5) 12 (3) .25
Iliac artery exposure 51 (18) 25 (7) <.001
Brachial artery exposure 5 (2) 3 (1) .26
LSCA, Left subclavian artery; TEVAR, thoracic endovascular aortic aneu-
rysm repair.
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were ﬁrst tested in a univariate fashion. In addition to vari-
ables associated with 30-day mortality on exploratory anal-
ysis (P < .1), those with biologic plausibility and previously
recognized risk factors were incorporated in a stepwise
fashion into the multivariable model. We determined a pri-
ori that any variable with >10% missing data would be
excluded from the mortality analysis. After deﬁning the
study cohort, there were no variables with >10% missing
data; thus, complete case analysis was used. The likelihood
ratio test and the Akaike information criterion in a nestedmodel approach were used to identify which covariates
increased the explanatory power of the model. The Akaike
information criterion favors selection of more parsimonious
models.16 The goodness of ﬁt of the regression was
assessed using the Pearson c2 statistic. Means are displayed
with standard errors and RR with 95% conﬁdence intervals
(CIs). Biostatistical analysis was performed with STATA
11SE software (StataCorp LP, College Station, Tex).
RESULTS
The cohort overall consisted of 649 patients, with 279
women (43%) and 370 men (57%). The average age was
71.3 6 0.7 years among women compared with 69.9 6
0.7 years for men (P ¼ .34). Baseline demographics are
reported in Table I, and there were few gender differences.
Women were less likely to have a history of alcohol use (1%
vs 5%; P < .001) or prior coronary bypass surgery (14% vs
27%; P < .001). Preoperative hematocrit was also lower in
women (36.6 vs 38.4; P < .001). Although not reaching
signiﬁcance, women tended to be more likely to have
insulin-dependent diabetes (P ¼ .14). Baseline functional
status was similar between the genders.
Operative characteristics are summarized in Table II.
Anesthesia type and surgical specialty did not differ accord-
ing to gender, and vascular surgeons performed most of
the TEVAR procedures. Operative time was signiﬁcantly
longer for women (173.6 6 6.3 vs 159.8 6 5.2 minutes;
P ¼ .03). The proportion of patients who underwent emer-
gency surgery did not differ by gender. With respect to
anatomic considerations (Table III), there was no differ-
ence in left subclavian artery coverage, use of proximal
extension cuffs, or adjunct left subclavian revascularization
procedures. Women were greater than twofold more likely
to require iliac artery exposure for arterial access (18% vs
7%; P < .001).
Outcomes. The number of reported intraoperative
complications (Table IV) within the NSQIP database was
low, with two women (1%) and one man (0.3%) requiring
cardiopulmonary resuscitation for cardiac arrest. One
woman and one man also sustained an intraoperative
myocardial infarction.
Overall 30-day mortality was 4.4% (n ¼ 29) and was
higher in women (6% [n ¼ 18] vs 3% [n ¼ 11]; P ¼ .03).
Although reaching statistical signiﬁcance, the absolute
difference in overall hospital length of stay was small
(women: 7.7 6 0.5 days vs men: 7.6 6 0.5 days;
P¼ .008). Frequently encountered postoperative complica-
tions are reported in Table V. Seventy-seven (28%) women
and 81 (22%) men were listed as having sustained a postop-
erative complication (P ¼ .08). According to gender,
women were more likely to develop a postoperative superﬁ-
cial wound infection (P ¼ .02) and coma >24 hours
(P ¼ .047) and tended to be more likely to develop postop-
erative bleeding requiring transfusion (P ¼ .11) and renal
insufﬁciency (P ¼ .07).
Multivariable analysis. Although there was a strong
trend, risk adjustment with multivariable logistic regression
analysis showed female gender did not reach statistical
Table IV. Univariate analysis of intraoperative
complications
Complication
Female
(n ¼ 284),
No. (%)
Male
(n ¼ 372),
No. (%) P
All intraoperative complications 4 (1) 4 (1) .84
Cardiac arrest requiring CPR 2 (1) 1 (0.3)
Myocardial infarction 1 (0.4) 1 (0.3)
Unplanned intubation 1 (0.4) 2 (1)
CPR, Cardiopulmonary resuscitation.
Table V. Univariate analysis of postoperative outcomes
and mortality
Outcomea
Female
(n ¼ 279)
Male
(n ¼ 370) P
Hospital length of stay, days 7.7 6 0.5 7.6 6 0.5 .008
Any complication 77 (28) 81 (22) .08
Wound infection 9 (3) 4 (1) .054
Superﬁcial 8 (3) 2 (1) .02
Deep 0 (0) 0 (0) -
Organ space 1 (0.4) 1 (0.3) .84
Dehiscence 1 (0.4) 1 (0.3) .84
Respiratory 31 (11) 31 (8) .24
Pneumonia 8 (3) 13 (4) .65
Unplanned intubation 16 (6) 16 (4) .41
Pulmonary embolism 1 (0.4) 2 (1) .74
Failure to wean ventilation 21 (8) 20 (5) .27
Renal 19 (7) 16 (4) .17
Renal insufﬁciency 6 (2) 2 (1) .07
Acute renal failure 5 (2) 4 (1) .44
Urinary tract infection 12 (4) 10 (3) .27
Neurologic 17 (6) 16 (4) .31
Stroke with neurologic deﬁcit 14 (5) 14 (4) .44
Coma >24 hours 3 (1) 0 (0) .046
Peripheral nerve injury 2 (1) 2 (1) .78
Cardiac 8 (3) 7 (2) .41
Cardiac arrest 6 (2) 6 (2) .62
Myocardial infarction 3 (1) 2 (1) .44
Bleeding requiring transfusion 25 (9) 21 (6) .11
Graft/prosthesis failure 2 (1) 3 (1) .89
Deep venous thrombosis 2 (1) 4 (1) .63
Infectious 16 (6) 16 (4) .41
Sepsis 12 (4) 8 (2) .12
Septic shock 4 (1) 8 (2) .50
Return to operating room 30 (11) 36 (10) .67
30-day mortality 18 (6) 11 (3) .03
aContinuous data are shown as the mean 6 standard error and categoric
data as number of patients (%).
Table VI. Multivariable generalized linear model
regression for operative mortality
Variable RR (95% CI) P
Female sex 2.30 (0.99-5.34) .053
Age 1.05 (1.01-1.09) .02
Body mass index 0.98 (0.95-1.01) .17
Angina 3.16 (0.99-10.05) .051
Dyspnea
Moderate exertion 0.92 (0.26-3.27) .90
At rest 2.01 (0.95-4.24) .07
Ventilator dependent 1.97 (0.63-6.15) .25
Stroke without deﬁcit 2.21 (0.77-6.32) .14
Bleeding disorder 2.95 (0.95-9.10) .06
Preoperative SIRS 2.79 (0.63-12.31) .18
Residency supervision 0.98 (0.70-1.36) .90
Emergency 3.76 (1.79-7.87) <.001
Iliac exposure 4.42 (2.07-9.44) <.001
CI, Conﬁdence interval; RR, relative risk; SIRS, systemic inﬂammatory
response syndrome.
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mortality (RR, 2.3; 95% CI, 0.99-5.34; P ¼ .053).
Advanced age, emergency surgery, and need for iliac artery
exposure were all characteristics independently associated
with greater odds of 30-day mortality (Table VI).
Although not reaching signiﬁcance, there was a strong
trend toward increased 30-day mortality for patients
with preoperative angina (P ¼ .051), bleeding disorder
(P ¼ .06), and dyspnea at rest (P ¼ .07). The remaining
variables included in the multivariable analysis were notindependently associated with 30-day mortality. The
Pearson c2 statistics was 0.9, indicating appropriate good-
ness of ﬁt for the model.
DISCUSSION
This study analyzed data provided by the ACS-NSQIP
to examine the inﬂuence of gender on perioperative
outcomes in 649 TEVAR patients who underwent repair
between 2005 and 2011. Patients with nonruptured
DTAAs were included, and we observed a 30-day mortality
rate of 4.4%, which is consistent with previously published
reports.4,14,17-20 The indication for TEVAR in this study
was a DTAA, and it is important to note that these results
may not be necessarily applicable to patients undergoing
TEVAR for other indications, such as dissection or post-
traumatic disruptions. Despite relatively similar baseline
risk proﬁles, women had higher absolute 30-day mortality
rates; however, an independent association was not
observed after risk adjustment in a multivariable regression.
Others have previously examined the effect of gender on
endovascular repairs, both in the infrarenal aortic position,
as well as single-center series examining TEVAR proce-
dures.9,11,17 Our study builds on the existing literature
by examining a large sample size provided by the NSQIP
database to study this question.
It is difﬁcult to ascertain the speciﬁc cause for the
higher 30-day mortality rate observed in women. When
comparing baseline demographics, we found no major
differences, with the exception that men were more likely
to have previously undergone coronary surgery and women
had lower baseline hematocrit levels. Because there was no
univariate association between hematocrit levels and
30-day mortality, this variable was unlikely to be
a confounder. There was also a trend toward women being
more likely to have preoperative angina; however, this did
not reach statistical signiﬁcance. Previous coronary surgery
was not identiﬁed as a risk factor for mortality in our anal-
ysis, but it is impossible to know if this variable reﬂects
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proportion of reconstructed coronary disease that is no
longer symptomatic. Because no signiﬁcant differences
were found in the rates of preoperative angina, we assume
that this reﬂects reconstructed disease rather than a risk for
mortality. This is also supported by the fact that there were
no differences in cardiac complications between the two
groups.
Functional status has been identiﬁed as a signiﬁcant
predictor of mortality after EVAR, but the functional
capacity of men and women was similar in this study.11
The remaining demographic characteristics were similar
between men and women, suggesting that baseline risk
proﬁles, within the constraints of the variables available
in the data set, do not explain the observed mortality
difference.
There were, however, signiﬁcant differences with
respect to operative characteristics. Women had longer
overall operative times and were also more likely to require
an iliac artery exposure for device delivery, which has been
observed in previous studies.8,9,11,17 The multivariable
logistic regression identiﬁed the need for an iliac artery
exposure as an independent predictor of 30-day mortality,
which may be responsible for the trend toward increased
risk of bleeding seen in the women. Women were nearly
three times more likely to require iliac artery exposure for
device delivery, and in the multivariable analysis, female
gender was no longer independently associated with higher
odds of mortality. This statistical ﬁnding suggests the need
for iliac artery exposure may have signiﬁcantly contributed
to the increased mortality seen in women on univariate
analysis. A similar phenomenon was observed in a gender
comparison performed in patients undergoing EVAR
repair only.11
Although not statistically signiﬁcant, there was a trend
toward increased major postoperative complications for
women (28% vs 22%, P ¼ .08). The incidence of overall
renal insufﬁciency and renal failure were relatively low,
but were each twice as common in women as in men.
Women demonstrated a trend toward increased postopera-
tive bleeding (P ¼ .11) and wound complications
(P ¼ .054). It is important to note that the NSQIP data-
base does not contain data regarding preoperative spinal
drain placement or the development of spinal cord
ischemia, a complication that is associated with nearly
double the 30-day TEVAR mortality observed in this
data set.21
Ehlert et al14 performed an analysis of TEVAR
outcomes in 440 patients using the NSQIP data set from
2005 to 2007.14 They similarly identiﬁed the need for iliac
conduit as an independent risk factor for serious adverse
events; however, their study included ruptured DTAAs,
and they did not perform a detailed breakdown of baseline
and operative risk according to gender. Czerny et al9 con-
ducted a retrospective review of their TEVAR experience in
286 patients and observed no mortality difference based on
gender. They did, however, identify increasing age and
chronic obstructive pulmonary disease as independentpredictors of mortality in a subanalysis of women only.
Although they performed rigorous statistical methodology,
their study may have been underpowered to detect a true
difference. Furthermore, their main outcomes were
1-year and 5-year survival, which differed from the primary
outcome we examined in this study. Our study builds on
these prior reports by providing a breakdown of operative
risk according to gender in a large sample size with sufﬁ-
cient statistical power to detect a true difference.
A substudy of the Evaluation of the Medtronic
Vascular Talent Thoracic Stent Graft System for the
Treatment of Thoracic Aortic Aneurysms (VALOR) trial
examined outcomes according to gender in 195 patients.17
They found worse early outcomes for women, although
women enjoyed greater freedom from aneurysm-related
complications in the long term. This ﬁnding is reinforced
by the observation in our study that women have an unad-
justed 30-day mortality rate twofold higher than men.
Abedi et al11 used the NSQIP data set to perform
a detailed analysis on the effect of gender after EVAR.
Unadjusted mortality was higher in women; however,
this result did not persist on multivariable analysis. When
considering the occurrence of postoperative complications,
female gender was a statistically signiﬁcant risk factor.
Women in that study were more likely to undergo emer-
gency surgery and require iliac or brachial artery exposure
for device delivery. These baseline differences were likely
driving the differences observed in unadjusted mortality
rates. Only 3% of women required iliac artery exposure
for EVAR, compared with 18% in our study, reﬂecting
the greater French device sizes of TEVAR delivery systems.
Owing to the retrospective study design, we cannot be
certain that all potential confounders have been identiﬁed.
Importantly, there is insufﬁcient information in the data-
base to determine hospital or surgeon volume, which has
been identiﬁed as an important predictor of outcomes for
many surgical procedures.22-25 The extent of aneurysm
affecting the thoracic aorta is not known, which also may
inﬂuence outcomes. Short-segment saccular aneurysms
may not be associated with similar operative risk as long-
segment thoracic aortic aneurysms. In addition, the data-
base does not distinguish between planned and urgent
iliac artery exposure. It is possible that in some cases, an
attempt was made to deliver the device through the
femoral vessels. The assumption is that an injury to the
artery did not occur, although this cannot be determined
from the database. The inability to control for these
variables is a limitation of this analysis.
Furthermore, large registry databases, such as the
ACS-NSQIP, rely heavily on accurate coding. Being one
of the prototypes of national surgical databases, the
ACS-NSQIP ensures proper training for data entry
personnel to ensure correct data recording. We have
assumed that any residual coding errors are random and
are thus unlikely to render any bias.
One can speculate on causes of death based on postop-
erative complications, but this variable is not coded in the
database. This information would be informative toward
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should be given to including this in future versions of the
NSQIP data set. In addition, this study is further limited
by the relatively short follow-up period, and thus, these
data do not provide information on the durability of
TEVAR repair according to gender. Recent studies have
shown that 30-day follow-up from the index hospitaliza-
tion likely underappreciates postdischarge mortality and
complications.26 An earlier substudy of the VALOR trial
identiﬁed equivalent successful aneurysm treatment at
1 year among men and women.17 This ﬁnding suggests
that the higher 30-day mortality observed in our study
may solely be related to periprocedural-related complica-
tions, and that once recovered from the initial TEVAR
procedure, women enjoy satisfactory long-term outcomes.
However, prospective, randomized trials of TEVAR
adhered to the strict instructions for use of each device.
The current study represents a real-world experience of
surgeons and patients across the country, and, as such,
the ﬁndings should caution surgeons to adequately counsel
women undergoing TEVAR with the need for iliac artery
exposure that they are likely to be at increased risk for peri-
operative death.
CONCLUSIONS
Using the ACS-NSQIP data set, we observed that
women have higher unadjusted 30-day mortality rates after
TEVAR for nonruptured thoracic aortic aneurysms,
although baseline risk proﬁles were similar based on gender.
However, this univariate association did not persist after risk
adjustment. On multivariable analysis, need for iliac artery
exposure, age, and emergency surgery were independently
associated with higher mortality rates. Need for
iliac exposure had the highest magnitude effect, and these
results suggest a need for decreased device delivery size
and improvements in endovascular technology.
The ACS NSQIP and the hospitals participating in the
ACS NSQIP are the source of the data used herein; they
have not been veriﬁed and are not responsible for the statis-
tical validity of the data analysis or the conclusions derived
by the authors.
AUTHOR CONTRIBUTIONS
Conception and design: GA, JB, YL, BP, JF, CA
Analysis and interpretation: GA, ES, DA, JB, YL, BP, JF, CA
Data collection: GA, ES, CA
Writing the article: GA, ES, DA, CA
Critical revisionof the article:GA,ES,DA, JB, YL,BP, JF,CA
Final approval of the article: GA, ES, DA, JB, YL, BP, JF, CA
Statistical analysis: GA, ES, CA
Obtained funding: Not applicable
Overall responsibility: GA
REFERENCES
1. Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP.
Transluminal placement of endovascular stent-grafts for the treatmentof descending thoracic aortic aneurysms. N Engl J Med 1994;331:
1729-34.
2. Bavaria JE, Appoo JJ, Makaroun MS, Verter J, Yu ZF, Mitchell RS.
Endovascular stent grafting versus open surgical repair of descending
thoracic aortic aneurysms in low-risk patients: a multicenter compara-
tive trial. J Thorac Cardiovasc Surg 2007;133:369-77.
3. Leurs LJ, Bell R, Degrieck Y, Thomas S, Hobo R, Lundbom J.
Endovascular treatment of thoracic aortic diseases: combined experi-
ence from the EUROSTAR and United Kingdom Thoracic Endograft
registries. J Vasc Surg 2004;40:670-9; discussion: 679-80.
4. Makaroun MS, Dillavou ED, Kee ST, Sicard G, Chaikof E, Bavaria J,
et al. Endovascular treatment of thoracic aortic aneurysms: results of
the phase II multicenter trial of the GORE TAG thoracic endopros-
thesis. J Vasc Surg 2005;41:1-9.
5. Makaroun MS, Dillavou ED, Wheatley GH, Cambria RP. Five-year
results of endovascular treatment with the Gore TAG device compared
with open repair of thoracic aortic aneurysms. J Vasc Surg 2008;47:912-8.
6. Matsumura JS, Cambria RP, Dake MD, Moore RD, Svensson LG,
Snyder S. International controlled clinical trial of thoracic endovascular
aneurysm repair with the Zenith TX2 endovascular graft: 1-year results.
J Vasc Surg 2008;47:247-57; discussion: 257.
7. Stone DH, Brewster DC, Kwolek CJ, Lamuraglia GM, Conrad MF,
Chung TK, et al. Stent-graft versus open-surgical repair of the thoracic
aorta: mid-term results. J Vasc Surg 2006;44:1188-97.
8. Czerny M, Funovics M, Ehrlich M, Hoebartner M, Sodeck G,
Dumfarth J, et al. Risk factors of mortality in different age groups after
thoracic endovascular aortic repair. Ann Thorac Surg 2010;90:534-8.
9. Czerny M, Hoebartner M, Sodeck G, Funovics M, Juraszek A,
Dziodzio T, et al. The inﬂuence of gender on mortality in patients after
thoracic endovascular aortic repair. Eur J Cardiothorac Surg 2011;40:
e1-5.
10. Mehta M, Byrne WJ, Robinson H, Roddy SP, Paty PS, Kreienberg PB,
et al. Women derive less beneﬁt from elective endovascular aneurysm
repair than men. J Vasc Surg 2012;55:906-13.
11. Abedi NN, Davenport DL, Xenos E, Sorial E, Minion DJ, Endean ED.
Gender and 30-day outcome in patients undergoing endovascular
aneurysm repair (EVAR): an analysis using the ACS NSQIP dataset.
J Vasc Surg 2009;50:486-91, 491e1-4.
12. Khuri SF, Henderson WG, Daley J, Jonasson O, Jones RS,
Campbell DA Jr, et al. The patient safety in surgery study: background,
study design, and patient populations. J Am Coll Surg 2007;204:
1089-102.
13. American College of Surgeons-National Surgical Quality Improvement
Program. User guide for the 2010 participant use data ﬁle. Available at:
http://site.acsnsqip.org/wp-content/uploads/2012/03/2010-User-
Guide_FINAL.pdf. Accessed July 14, 2012.
14. Ehlert BA, Durham CA, Parker FM, Bogey WM, Powell CS,
Stoner MC. Impact of operative indication and surgical complexity on
outcomes after thoracic endovascular aortic repair at National Surgical
Quality Improvement Program Centers. J Vasc Surg 2011;54:
1629-36.
15. Zou G. A modiﬁed Poisson regression approach to prospective studies
with binary data. Am J Epidemiol 2004;159:702-6.
16. Posada D, Buckley TR. Model selection and model averaging in
phylogenetics: advantages of Akaike information criterion and bayesian
approaches over likelihood ratio tests. Syst Biol 2004;53:793-808.
17. Jackson BM, Woo EY, Bavaria JE, Fairman RM. Gender analysis of the
pivotal results of the Medtronic Talent Thoracic Stent Graft System
(VALOR) trial. J Vasc Surg 2011;54:358-63, 363e1.
18. Goodney PP, Travis L, Lucas FL, Fillinger MF, Goodman DC,
Cronenwett JL, et al. Survival after open versus endovascular thoracic
aortic aneurysm repair in an observational study of the Medicare
population. Circulation 2011;124:2661-9.
19. Bhamidipati CM, LaPar DJ, Mehta GS, Kern JA, Kron IL,
Upchurch GR Jr, et al. Have thoracic endografting outcomes improved
since US Food and Drug Administration approval? Ann Thorac Surg
2011;91:1314-22; discussion: 1322.
20. Orandi BJ, Dimick JB, Deeb GM, Patel HJ, Upchurch GR Jr.
A population-based analysis of endovascular versus open thoracic aortic
aneurysm repair. J Vasc Surg 2009;49:1112-6.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 1 Arnaoutakis et al 5121. Ullery BW, Cheung AT, Fairman RM, Jackson BM, Woo EY,
Bavaria J, et al. Risk factors, outcomes, and clinical manifestations of
spinal cord ischemia following thoracic endovascular aortic repair.
J Vasc Surg 2011;54:677-84.
22. Arnaoutakis GJ, George TJ, Allen JG, Russell SD, Shah AS, Conte JV,
et al. Institutional volume and the effect of recipient risk on short-term
mortality after orthotopic heart transplant. J Thorac Cardiovasc Surg
2012;143:157-67, 167e1.
23. Brooke BS, Perler BA, Dominici F, Makary MA, Pronovost PJ.
Reduction of in-hospital mortality among California hospitals meeting
Leapfrog evidence-based standards for abdominal aortic aneurysm
repair. J Vasc Surg 2008;47:1155-64; discussion: 1663-4.24. Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of
regionalization on cost and outcome for one general high-risk surgical
procedure. Ann Surg 1995;221:43-9.
25. Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized?
The empirical relation between surgical volume and mortality. 1979.
Clin Orthop Relat Res 2007;457:3-9.
26. Yu P, Chang DC, Osen HB, Talamini MA. NSQIP reveals signiﬁcant
incidence of death following discharge. J Surg Res 2011;170:e217-24.Submitted Mar 14, 2013; accepted Jun 11, 2013.
